Skip to main content

Verve Therapeutics, Inc.

VERVDelisted Jul 25, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001840574

Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Verve Therapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of VERV: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders069+69
Shares037.7M+37.7M
Value$0$2.25B+$2.25B

New holders (69)

Institutions that held Verve Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to VERV in Q2 2021
InstitutionSharesValue% of portfolio
Alphabet Inc.10,974,011$661.2M13.47%
Wellington Management Group LLP3,965,479$232.1M0.04%
FMR LLC3,449,794$207.9M0.02%
Casdin Capital, LLC3,038,167$183.1M4.65%
Redmile Group, LLC1,936,530$116.7M1.73%
Baker Bros. Advisors LP1,416,530$85.3M0.37%
Janus Henderson Group PLC1,413,771$79.8M0.03%
Rock Springs Capital Management LP962,826$58.0M1.15%
JPMorgan Chase & Co920,252$55.4M0.01%
Ra Capital Management, L.P.880,284$53.0M0.85%
Citadel Advisors LLC829,589$48.7M0.05%
Novo Holdings A/S793,265$47.8M2.12%
Logos Global Management LP758,265$45.7M3.92%
Price T Rowe Associates Inc685,000$41.3M0.00%
Cormorant Asset Management, LP709,224$40.6M1.58%
ARK Investment Management LLCSuperinvestorARK Invest548,389$33.0M0.06%
BlackRock Inc.529,924$31.9M0.00%
Artal Group S.A.500,000$30.1M0.69%
Adage Capital Partners GP, L.L.C.451,680$27.2M0.05%
Millennium Management LLC409,994$24.7M0.03%
Jennison Associates LLC370,000$22.3M0.01%
Federated Hermes, Inc.370,000$22.3M0.04%
Woodline Partners LP206,921$12.5M0.23%
Goldman Sachs Group Inc118,513$7.14M0.00%
Darwin Global Management, Ltd.103,013$6.21M1.00%
OrbiMed Advisors LLC100,000$6.03M0.06%
Alyeska Investment Group, L.P.100,000$6.03M0.07%
Suvretta Capital Management, LLC100,000$6.03M0.09%
EcoR1 Capital, LLC100,000$6.03M0.23%
Vanguard Group Inc65,000$3.92M0.00%
Polar Capital Holdings Plc65,000$3.92M0.02%
HRT Financial LP62,159$3.75M0.03%
TRB Advisors LP60,000$3.62M0.82%
Pura Vida Investments, LLC59,393$3.58M0.26%
D. E. Shaw & Co., Inc.57,819$3.48M0.00%
Balyasny Asset Management LLC47,749$2.88M0.02%
EAM Global Investors LLC40,055$2.41M0.67%
Blair William & Co35,600$2.15M0.01%
Great Point Partners LLC35,000$2.11M0.47%
Pinz Capital Management, LP34,800$2.10M0.63%
Geode Capital Management, LLC32,102$1.93M0.00%
Squarepoint Ops LLC31,253$1.88M0.01%
Moore Capital Management, LP30,446$1.83M0.03%
Susquehanna International Group, LLP28,525$1.72M0.00%
EAM Investors, LLC28,413$1.71M0.26%
Ameriprise Financial Inc26,282$1.58M0.00%
united american securities inc. (d/b/a uas asset management)25,000$1.51M0.37%
LMR Partners LLP25,000$1.51M0.02%
Asymmetry Capital Management, L.P.24,790$1.49M1.03%
Marshall Wace North America L.P.18,451$1.11M0.00%
Caas Capital Management LP15,000$904.0K0.05%
Qube Research & Technologies Ltd12,730$767.0K0.01%
Ghisallo Capital Management LLC10,000$603.0K0.02%
Jane Street Group, LLC9,492$572.0K0.00%
Tudor Investment Corp Et Al7,904$476.0K0.01%
Royal Bank of Canada7,100$428.0K0.00%
Virtu Financial LLC6,822$411.0K0.04%
Alliancebernstein L.P.6,219$375.0K0.00%
Maven Securities LTD5,556$361.0K0.04%
Point72 Hong Kong Ltd5,700$343.0K0.02%
ExodusPoint Capital Management, LP5,345$322.0K0.01%
Capstone Investment Advisors, LLC5,000$301.0K0.01%
Morgan Stanley2,468$149.0K0.00%
Sandy Spring Bank1,600$96.0K0.01%
UBS Group AG1,531$92.0K0.00%
Bank of America Corp372$22.0K0.00%
Cubist Systematic Strategies, LLC351$21.0K0.00%
Lindbrook Capital, LLC300$18.0K0.00%
Wells Fargo & Company100$6.00K0.00%

Sold out (0)

Institutions that held Verve Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

None.